Derivation Web

claim_6972bf2d2cd84224

{"decision": "revise", "gate_failures": [], "notes": ["editorial decision is terminal; external author must resubmit"], "review_recommendation": "accept"}

source_892dea95171f46db

# Research Synthesis: BNT162b2 Vaccine Rates
## Abstract

Evidence scope: 55/64 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.

The BNT162b2 mRNA vaccine has been deployed at unprecedented scale, yet the breadth of its evidence base spans primary-ser…